News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Patent News (World)
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent in Spain For Oral Administration Of Insulin 8/19/2014
EnGeneIC Pty Ltd Receives Patent From The USPTO For EDV™ Nanocell Technology 8/11/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement With DinoNa For Leukotuximab 8/8/2014
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 8/6/2014
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014 7/24/2014
Drawbridge Pharmaceuticals Extends Phaxan™ Patent Portfolio With Divisional Patents Granted For Other Neuroactive Steroids 7/22/2014
BMC To Actively Defend Against Curative In Patent Fight 7/18/2014
Prima Biomed (PRR.AX) Receives U.S. Patent Grant For CVac 7/16/2014
C4X Discovery Patent Granted In Japan 7/15/2014
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014
Microbix Biosystems Inc. (MBXBF) Sues Novartis AG (NVS) For Infringement Of Its VIRUSMAX® Patent In Europe 7/10/2014
Access Pharmaceuticals (ACCP) Awarded Hong Kong Patent For MuGard 7/8/2014
BioLight Announces Issuance Of U.S. Patent For The Long-Term Controlled-Release Drug-Delivery Insert Platform 7/2/2014
Orexo AB (ORXOF) Commences Patent Infringement Litigation Against Actavis (ACT) 6/27/2014
TWi Biotechnology Receives Notice Of Patent Allowance For Its Lead Drug Candidate AC-201 In United States 6/26/2014
Pluristem Therapeutics (PSTI) Granted Patent In Russia For Treatment Of Inflammatory Bowel Disease Using Placenta-Derived Cells 6/19/2014
Arjuna Natural Extracts Ltd Receives Two Japanese Patents For BCM- 95® 6/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Reaches Settlements In NUVIGIL® Patent Case 6/17/2014
Pluristem Therapeutics (PSTI) Receives Patent In India For Cell Therapy Production Methods And Compositions 6/16/2014
Milan District Court Confirms The Validity Of Alfa Wasserman's Rifaximin-Alpha Patents 6/12/2014
Galmed Pharmaceuticals Announces The Filing Of A Provisional Patent Application For The Use Of Aramchol For The Treatment Of Lipodystrophy 6/9/2014
Scancell: DNA ImmunoBody Patent Granted In United States 6/5/2014
Suven Life Sciences Ltd Secures One Product Patent In U.S.A. 6/4/2014
ERYtech Pharma Strengthens Its Intellectual Property Portfolio 6/2/2014
Actavis (ACT) Confirms Generic Onglyza® Patent Challenge 5/28/2014
Can-Fite BioPharma (CFBI) Receives Patent In European Union For Treatment Of Liver Function Following Surgery 5/8/2014
Alcobra (ADHD) Issued New US Patent Covering Metadoxine Use For Cognitive Disorders 5/1/2014
Actavis (ACT) Announces Celebrex® Patent Challenge Settlement 4/24/2014
TWi Pharmaceuticals, Inc. Announces Settlement Of Lidoderm® Patent Litigation 4/23/2014
Foamix Announces The Issuance Of Five Additional U.S. Patents 4/21/2014
Drawbridge Pharmaceuticals Announces Successful Clinical Trial Results For Phaxan™ And Grant Of U.S. Patent 4/16/2014
Depomed, Inc. (DEPO) Announces Settlements With Two Gralise® ANDA Filers 4/14/2014
Critical Pharmaceuticals Limited Receives Notice Of Allowance From US Patent And Trademark Office For Intranasal Growth Hormone And Parathyroid Hormone Products 4/8/2014
GlaxoSmithKline (GSK)'s ViiV Healthcare Unit Adds New HIV Drug To AIDS Patent Pool 4/2/2014
Enzymotec Provides Update On Patent Litigation With Neptune Technologies & Bioressources Inc. 4/1/2014
Suven Life Sciences Ltd Secures (2) Product Patents For Their NCEs In U.S.A. 3/26/2014
Merck & Co., Inc. (MRK) HIV Drug Strategy Seen Shielding Patent 3/21/2014
Actavis (ACT) Announces Daytrana® Patent Challenge Settlement 3/20/2014
Settlement Between BioPorto And Phadia AB In Patent Case 3/3/2014
Fibrotech Is Granted U.S. And Canadian Patents For Its Anti-Fibrotic Compounds 3/3/2014
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 2/25/2014
Can-Fite BioPharma (CFBI) Granted Patent On The Manufacturing Of CF101 In Japan 2/25/2014
ISA Pharmaceuticals Strengthens Patent Protection For Its Lead Product ISA101 2/24/2014
Scancell: Publication Of Moditope Patent 2/18/2014
Pluristem Therapeutics (PSTI) Receives Key 3D Cell Expansion Patent In Australia 2/18/2014
BioAlliance Pharma: Strengthening And Extension Of The Industrial Protection Of Livatag® Until 2031 2/18/2014
OvaScience (OVAS) Issued Two U.S. Patents Covering AUGMENT? Fertility Treatment 2/12/2014
Actavis (ACT) Confirms Generic Treanda® Patent Challenge 2/4/2014
Enzymotec Announces It Has Been Granted Patents For INFAT®'S Uses In Canada And The US 2/3/2014
Suven Life Sciences Ltd Product Patents For Their NCEs In Canada, China And India 1/31/2014
Microbix Biosystems Inc. (MBXBF) Wins VIRUSMAX® Patent Challenge In Europe 1/23/2014
Anergis Obtains Core Technology Patent In Japan 1/14/2014
Adocia Strengthens Its Diabetic Foot Ulcer Patent Portfolio 1/13/2014
BrainStorm Cell Therapeutics Inc. Receives United States Patent Office Notice Of Allowance For Its Stem Cell Technology 1/13/2014
Suven Life Sciences Ltd Three (3) Product Patents For Their Nces In Australia, Sri Lanka And South Korea 1/9/2014
Pluristem Therapeutics (PSTI) Receives Key Placental Cell Therapy Patent in Australia 1/8/2014
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance To Grant European Patent Covering Its Stem Cells For The Treatment Of CNS Diseases 1/8/2014
Veloxis Pharmaceuticals A/S (VELO) Receives Notice Of Allowance From U.S. Patent Office For Diurnal-Independent Administration Of Envarsus® 1/8/2014
Enzymotec Granted Patent For A Lipid Preparation Use Method 1/6/2014
Actavis (ACT) Confirms Generic NuvaRing® Patent Challenge 12/27/2013
Caris Life Sciences Receives Patent For Molecular Profiling Service In The People's Republic Of China 12/17/2013
Scancell's DNA ImmunoBody® Patent Granted In Japan 12/12/2013
MorphoSys AG Strengthens European Patent Position On Anti-CD19 Cancer Program MOR208 12/3/2013
Amarin Corporation PLC (AMRN) Announces Notification Of Patent Allowances For U.S. Applications 13/685,281, And 13/685,291 Related To Triglyceride Lowering With A Mixture Of Omega-3 Free Fatty Acid (Including EPA And/Or DHA) In Both The MARINE And ANCHOR Patient Populations 12/2/2013
TopoTarget A/S Release: Allowance Of Key Belinostat Patent In Europe 11/21/2013
Plasticell Release: Additional Family Of CombiCult® Patents Granted In USA, Europe, Australia And Singapore 11/18/2013
BioAlliance Pharma Strengthens Sitavig Patent Protection With New U.S. And South Korean Issued Patents 11/14/2013
Zysis Receives U.S. Patent for Long Acting Oral Aripiprazole Once Weekly 11/13/2013
Can-Fite BioPharma (CFBI) Release: U.S. Patent and Trademark Office Grants a Patent for the Reduction of Intraocular Pressure 11/6/2013
Suven Life Sciences Ltd Secures Two (2) Product Patents for Their NCEs in U.S.A. and Japan 11/6/2013
Enzymotec Granted Patent for Its Composition of Vayacog® Addressing Memory and Mild Cognitive Impairment 10/30/2013
Drawbridge Pharmaceuticals Granted New Anaesthesia Patents for Phaxan™ 10/28/2013
Immunicum's Patent Application Regarding the Company’s Core-Technology for Therapeutic Cancer Vaccination Using Allogeneic Dendritic Cells is Being Approved in the U.S. 10/25/2013
Merus Granted European Patent on MeMo®, a Transgenic Mouse for Generating the Building Blocks of Therapeutic Human Bispecific Antibodies 10/23/2013
Mystic Pharmaceuticals Receives Notices of Allowance From Japan and China on Drug Delivery Platform Technologies 10/1/2013
Suven Life Sciences Ltd Secures Three (3) Product Patents for Their New Chemical Entities, Inc.'s in New Zealand, Singapore and South Korea 9/25/2013
Mylan Inc. (MYL) Will Not Shy Away From Pursuing "Frivolous" Patents 9/12/2013
Pluristem Therapeutics (PSTI) Granted Key U.S. Patent for the Treatment of Peripheral Artery Disease 9/11/2013
Roche (RHHBY) Gives Up on India Patent for Breast Cancer Drug 8/16/2013
Suven Life Sciences Ltd Secures Two (2) Product Patents for Their New Chemical Entities, Inc.'s in Europe 8/8/2013
Roche (RHHBY) Cancer Drug Suffers Patent Setback in India 8/6/2013
China's SIPO Voids Patent for Gilead Sciences, Inc. (GILD)'s Viread 7/30/2013
Indian Ministry Wants to Cancel Patent on Roche (RHHBY) Cancer Drug 7/26/2013
Riboxx Announces RNA Manufacturing Patent Grant by EPO 7/17/2013
Genetic Technologies Limited (GTG.AX) Announces U.S. Patent Office Allows First Patent for ImmunAid 7/10/2013
Suven Life Sciences Ltd Secures Two Product Patents for Their NCEs in Japan and U.S.A. 6/28/2013
As Field Hots Up, Virttu Biologics Secures U.S. Patent Allowance on Next-Generation Oncolytic Virus Candidates Engineered to Express Antisense Sequences 6/25/2013
Kamada Ltd. (KMDA.TA) Granted Two Key Patents 6/24/2013
Anergis Files Provisional U.S. Patent on AllerDM Dust Mite Allergy Treatment 6/13/2013
QRxPharma Pty Ltd. Granted US Patent on Hybrid Opioids 6/12/2013
Patrys Limited (PAB.AX) Granted Key Patent for Lead Product – PAT-LM1 6/7/2013
Verva Pharmaceuticals Announces Grant of United States Patent for Type 2 Diabetes Therapy VVP808 and Results of Annual General Meeting 6/3/2013
Ockham Overturns Vectura Group plc (VEC.L)'s Challenge to Secure European Patent Rights for Inhaled Heparin in the Treatment of COPD 6/3/2013
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/417,899 Related to Combination Product of Vascepa® and Statin Therapy 5/22/2013
New Japanese Protozoal Patent for BioDiem Ltd. (BDM.AX)'s BDM-I 5/22/2013
European and U.S. Cellulase Patents Granted to DIREVO Industrial Biotechnology GmbH 5/21/2013
Biotage AB (BIOTa.ST) and Peptide Synthesis 5/13/2013
Suven Life Sciences Ltd Secures Three Product Patents for Their NCEs in Canada and Eurasia 5/10/2013
Novartis AG (NVS) Sees Boost From Program Designed to Speed Life-Saving Therapies 5/6/2013
Imugene Limited (IMU.AX) Granted Chinese Patent for Novel Drug Delivery Technology 4/30/2013
Teva Pharmaceutical Industries Limited (TEVA) Welcomes Landmark "Victory for Patient" in Intellectual Property Case 4/30/2013
GW Pharmaceuticals Announces U.S. Patent Allowance for SATIVEX® Formulation Spray Device 4/22/2013
ARTES Biotechnology Issued New Patent in Australia for VLP Technology 4/22/2013
Addex Therapeutics (ADXN.SW) Announces Issuance of a Broad European Composition of Matter Patent for Dipraglurant 4/22/2013
Medgenics, Inc. Receives Notice of Allowance From the U.S. Patent Office for Claims That Expand IP for Its Platform Technology to Additional Therapeutic Proteins 4/22/2013
Starpharma Holdings Ltd Granted New Drug Delivery Patents 4/17/2013
Suven Life Sciences Ltd Secures 4 Product Patents for Their NCEs in China, Mexico and New Zealand 4/17/2013
Prima Biomed (PRR.AX) Awarded Japanese Patent for CVac™ 4/17/2013
Celsus Therapeutics Announces Notification of Patents Granted 4/17/2013
Glenmark Pharmaceuticals to Respond to Patent Row With Merck & Co., Inc. (MRK) Next Month 4/15/2013
AstraZeneca PLC (AZN) Suffers Fresh Drug Patent Setback in U.S. 4/2/2013
Novartis AG (NVS) Loses Cancer Drug Glivec Patent Case 4/1/2013
European Patent Office to Grant Patent for Macrocure's CureXcell® 3/21/2013
Genetic Technologies Limited (GTG.AX) Provides U.S. Patent Re-Examination Update 3/15/2013
Allergy Therapeutics plc Granted U.S. Patent for Sublingual Administration of MPL Adjuvant and Vaccine Antigens 3/11/2013
Alchemia Granted Key U.S. Patent 3/6/2013
India Rejects Bayer AG (BAY.F) Plea Against Cheap Cancer Drug 3/5/2013
Additional Patent Granted in China for BioDiem Ltd. (BDM.AX)'s Antimicrobial 2/21/2013
BioIndustry Association Release: New Patent Court Makes UK Natural European Home for Global Life Science Businesses 2/19/2013
Bristol-Myers Squibb Company (BMY): Patent on $1.4 Billion Hepatitis-B Treatment Invalid; Teva Pharmaceutical Industries Limited (TEVA) to Benefit 2/13/2013
Biotech Support Group Release: Use of Cleanascite™ in "Method and Pharmaceutical Composition for Treatment of Intestinal Disease" 2/12/2013
MorphoSys AG Receives First Patent on Novel Antibody Platform Ylanthia in the U.S. 2/8/2013
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice of Allowance From Chinese Patent Office for Treatment and Prevention of Heart Disease 2/8/2013
Mesoblast Limited Release: Key Mesenchymal Precursor Cell Patents Granted in United States and China 2/7/2013
AmpliPhi Biosciences (TGEN) Receives Notice of Allowance on Key Patent for its Bacteriophage Therapy to Treat Drug-Resistant Biofilm-based Infections 2/4/2013
Amarin Corporation PLC (AMRN) Announces Notification of Additional U.S. Patent Allowance for U.S. Application 13/272,520 Based on ANCHOR Clinical Trial Results 2/1/2013
Amarin Corporation PLC (AMRN) Announces Notification of Two Additional Patent Allowances for U.S. Applications (13/458,496 and 13/349,157) Related to Vascepa® and FDA Approved MARINE Indication 1/31/2013
Amarin Corporation PLC (AMRN) Announces First Notification of U.S. Patent Allowance Based on ANCHOR Clinical Trial Results 1/24/2013
Anergis Obtains U.S. Patent for Lead Product AllerT 1/23/2013
Addex Therapeutics (ADXN.SW) Announces Issuance of a Broad U.S. Composition of Matter Patent for ADX71441 1/22/2013
Kiadis Pharma Granted U.S. Patent for its Blood Cancer Treatment ATIR™ 1/22/2013
Biotage AB (BIOTa.ST) Success in Re-Examination Proceedings 1/16/2013
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/610,217 Related to Vascepa® and FDA Approved MARINE Indication 1/11/2013
RedHill Biopharma Ltd. (RDHL) Announces Issuance of New U.S. Patent and Provides Update on RHB-104 for Treatment of Crohn's Disease 1/7/2013
Alkermes plc (ALKS) Announces Notice of Allowance of Key U.S. Patent for Aripiprazole Lauroxil, a New Schizophrenia Drug Candidate 1/3/2013
Suven Life Sciences Ltd Secures 3 Product Patents for Their New Chemical Entities, Inc.'s in Eurasia & Canada 1/2/2013
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/623,450 Related to Vascepa® and FDA Approved MARINE Indication 12/13/2012
MorphoSys AG Strengthens Patent Position on anti-CD38 Cancer Program MOR202 12/6/2012
Medgenics, Inc. Key Patent Claims Allowed in Japan Protecting Core Technology to be Used in Hepatitis Treatment 12/6/2012
Takara Bio Grants Patent License to InVivoScribe Technologies, Inc. for FLT3-ITD Testing in Japan 12/5/2012
Rainbow BioSciences, LLC Target Amarantus BioSciences, Inc. Wins MANF Patent Challenge in Europe 12/5/2012
Axiogenesis Earns U.S. Patent With In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy 12/4/2012
Indian Board Rejects AstraZeneca PLC (AZN)'s Patent Plea on Cancer Drug 11/28/2012
Rhenovia Files Two Patent Applications for RHEpatch™, an Electronic Transdermal Patch for Controlled Drug Delivery 11/28/2012
Medgenics, Inc. Granted U.S. Patent for Core Technology Used in Sustained Delivery of Erythropoietin, Aimed at Multi-Billion Dollar Anemia Market 11/21/2012
Japanese Patent Office to Grant BioDiem Ltd. (BDM.AX) New Patent for BDM-I Antimicrobial 11/21/2012
Marinomed Biotechnologie GmbH Granted Chinese Patent for Antiviral Polymer 11/19/2012
MediciNova, Inc. Extends MN-166 Patent Position in Europe 11/19/2012
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/608,775 Related to Vascepa® and FDA Approved MARINE Indication 11/19/2012
New Patent Covering PROLOR Biotech (PBTH)'s Reversible-Pegylation Platform Technology is Allowed by U.S. Patent Office 11/13/2012
India Revokes Roche (RHHBY) Patent in New Blow for Big Pharma 11/5/2012
InDex Pharmaceuticals AB Granted Japanese Patent for Novel Treatment of Steroid-Resistant Inflammation 10/24/2012
Amarin Corporation PLC (AMRN) Announces Issuance of U.S. Patents 8,793,727 and 8,293,728 for Vascepa™ 10/23/2012
Adocia is Extending Its Intellectual Property to New Formulations of Monoclonal Antibodies 10/22/2012
InteRNA Technologies Receives Notice of Allowance for miRNA Sequences of Its Lead Pre-Clinical Product 10/15/2012
Laurantis Pharma Oy Issued Patent for Cis-UCA as a Treatment for Bladder Cancer 10/9/2012
Alnylam Pharmaceuticals (ALNY) Announces Tuschl II Key Patent Claims Upheld in Invalidation Trial in Japan 10/9/2012
India Revokes Patent for Pfizer Inc. (PFE)'s Sutent 10/4/2012
Suven Life Sciences Ltd Bags Pharmexcil's "Platinum Patent Award" 10/4/2012
BioLineRx Ltd. Receives Notice of Allowance From USPTO for New Patent on BL-1020, Extending Patent Protection Until 2031 9/24/2012
Cardiolynx Receives Patent on Improved Angina Pectoris Drug 9/20/2012
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/284,408 Related to Vascepa™ and FDA Approved MARINE Indication 9/6/2012
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowances for U.S. Applications 12/702,889 and 13/349,153 Related to Vascepa™ and FDA Approved MARINE Indication 9/5/2012
Public Not to be Hit if Natco Pharma Limited Licence Cancelled: Bayer Corporation (BAY) 9/4/2012
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/282,145 Related to Vascepa™ and FDA Approved MARINE Indication 9/4/2012
InDex Pharmaceuticals AB Strengthens IP Position for Kappaproct 9/4/2012
U.S. Patent Granted for Verona Pharma's RPL554 8/28/2012
China Botanic Receives New Patent on Its Comprehensive Method to Enhance the Medicinal Value of Schisandra 8/28/2012
Suven Life Sciences Ltd Secures 4 Product Patents for Their NCEs in Australia, Canada, Korea and New Zealand 8/9/2012
BioDiem Ltd. (BDM.AX) Granted European Patent for BDM-I Antimicrobial 8/7/2012
DiaGenic ASA: Notice of Allowance of Breast Cancer Patent in Japan 8/3/2012
U.S. Patent Office Allows Laurantis Pharma Oy Application for Treatment of Skin Inflammation 8/1/2012
Agennix AG Announces Notice of Allowance for U.S. Patent Application Covering Use of Talactoferrin Alfa to Treat Non-Small Cell Lung Cancer and Renal Cancer in Combination With Other Treatments 7/30/2012
Amarin Corporation PLC (AMRN) Receives Notice of Intention to Grant on European Patent 7/25/2012
BioAlliance Pharma Extends and Strengthens the Protection of AMEP® With the Grant of Two Patents in the US 7/12/2012
Novartis AG (NVS) India Patent Case Postponed to August 22 7/9/2012
BioLineRx Ltd. Receives Notice of Intention to Grant Additional European Patent Covering BL-1020, for the Treatment of Schizophrenia 7/9/2012
Danisco Wins European Patent Office Appeal as Board Revokes Novozymes A/S (NZYMb.CO) Animal Feed Patent 7/6/2012
Amarin Corporation PLC (AMRN) Announces Notice of Allowance for Additional U.S. Patent Covering AMR101 7/2/2012
PolyTherics Granted Further Patents for TheraPEG™ and GlycoPol™ 6/18/2012
InnaVirVax Strenghtens Patent Protection of VAC-3S Immunotherapy 6/18/2012
Bionor Pharma ASA Release: International Patent Application Submitted Covering Vaccines for Influenza (Universal Vaccine), Hepatitis C, Cytomegalovirus and Human Papillomavirus 6/7/2012
Bionor Pharma ASA Release: International Patent Application Submitted for the Therapeutic and Potentially Preventive Vaccine Vacc-HIV, Combining Bionor's Vacc-4x and Vacc-C5 6/7/2012
BioLineRx Ltd. Announces Receipt of Two Notices of Allowance from USPTO for Patents Covering BL-1021, an Orally Available New Chemical Entity for Treatment of Neuropathic Pain 6/5/2012
Rhenovia Files Patents for New Treatment of Huntington's Disease Based on Its Innovative Biosimulation Platform 5/31/2012
Amarin Corporation PLC (AMRN) Announces U.S. Patent Issuance for AMR101 5/29/2012
Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Core Technology Patent in New Zealand 5/29/2012
Patrys Limited (PATZF.PK) Granted Key Patent for Lead Product -- PAT-SM6 5/24/2012
Suven Life Sciences Ltd Secures 4 Product Patents for their NCEs in Japan, Australia, Europe and Eurasia 5/22/2012
Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Israeli Patent for Its Core Technology in Oral Delivery of Proteins 5/16/2012
New US Patent Grant for ValiRx Plc's Cancer Screening Gene Biomarker 5/15/2012
Agenix Limited: New Patent Granted in Japan Enhances Value of Revolutionary New Australian Blood Clot Diagnostic Technology 5/14/2012
Nitto Denko Corporation (XETRA: ND5.DE) Obtains US Patent for Antifibrotic Therapies with Molecular Targeting DDS Technology 5/10/2012
BioDiem Ltd. (BDM.AX) Release: BDM-I Patent Position Strengthened With New US Patent Relating to Malaria and Trichomoniasis 5/3/2012
Quotient Receives Final Patent Approval for Its Enteriontm Technology – the Industry's Leading Clinical Technology for Investigating Drug Absorption 5/1/2012
U.S. Court Invalidates Two Sanofi (France) (SAN.PA) Taxotere Patents 4/11/2012
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Four New Patents and Allowances in Mexico and Israel 4/9/2012
Suven Life Sciences Ltd Secures 4 Product Patents for their NCEs in China and Korea 4/3/2012
Supreme Court Knocks Back Myriad Genetics, Inc. (MYGN) Patents 3/28/2012
Ideal Cures Pvt. Ltd. Receives Key US Patent for Sodium Alginate Based Aqueous Film Coating Technology 3/27/2012



//-->